FDA Drug Application (201961) for PHENTERMINE HYDROCHLORIDE by LANNETT HOLDINGS INC

Back to FDA Applications sponsored by LANNETT HOLDINGS INC

Application Number201961
Product Number001
FormCAPSULE;ORAL
Dosage37.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AA Products in conventional dosage forms not presenting bioequivalence problems
Reference Drug
Drug NamePHENTERMINE HYDROCHLORIDE
Active IngredientPHENTERMINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient PHENTERMINE HYDROCHLORIDE11


Back to FDA Applications sponsored by LANNETT HOLDINGS INC